🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

JPMorgan bullish on EssilorLuxottica stock, expects stronger sales in Q4

EditorEmilio Ghigini
Published 10/18/2024, 03:32 PM
ESLOY
-

On Friday, JPMorgan updated its outlook on EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price target to €225 from the previous €215 while maintaining an Overweight rating on the stock. This adjustment comes in the wake of the company's third-quarter trading update, which was released after the market closed yesterday.

EssilorLuxottica's Q3 report indicated a growth in group sales of 4.0% excluding foreign exchange impacts, which was slightly below JPMorgan's estimate of 4.9%. The shortfall was attributed to slower performance in the European and Asia-Pacific markets, particularly within the Professional Solutions channel. Despite this, management expressed confidence during the earnings call, highlighting the sun business's return to positive growth in September and projecting an upward trend for the fourth quarter.

Management's optimism extended to the company's innovative efforts, noting strong growth in the Stellest line, with a 40% increase in China and a 70% surge in Europe from a small base. Additionally, they anticipate continued momentum from the Ray-Ban Meta (NASDAQ:META) collaboration and the upcoming launch of Nuance by the end of 2024 or early 2025.

JPMorgan's revised profit forecast for EssilorLuxottica factors in the softer third-quarter performance, which is expected to partially roll into the fourth quarter. However, the first-time consolidation of Supreme and Heidelberg is projected to add approximately €600 million in incremental revenue, or 2% against the FY24 base. With these considerations and a forward-rolled discounted cash flow analysis to December 2026, JPMorgan has set the new price target for EssilorLuxottica shares.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.